Bristlecone Advisors’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$95K Hold
36,000
0.01% 239
2025
Q1
$108K Buy
+36,000
New +$108K 0.01% 290